Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Inventory Average: 2011-2025

Historic Inventory Average for Myriad Genetics (MYGN) over the last 13 years, with Sep 2025 value amounting to $30.1 million.

  • Myriad Genetics' Inventory Average rose 15.30% to $30.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.1 million, marking a year-over-year increase of 15.30%. This contributed to the annual value of $24.8 million for FY2024, which is 17.58% up from last year.
  • Latest data reveals that Myriad Genetics reported Inventory Average of $30.1 million as of Q3 2025, which was up 5.79% from $28.5 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Inventory Average ranged from a high of $30.1 million in Q3 2025 and a low of $15.4 million during Q1 2022.
  • For the 3-year period, Myriad Genetics' Inventory Average averaged around $25.3 million, with its median value being $25.4 million (2024).
  • In the last 5 years, Myriad Genetics' Inventory Average tumbled by 40.23% in 2022 and then soared by 42.90% in 2023.
  • Myriad Genetics' Inventory Average (Quarterly) stood at $16.9 million in 2021, then increased by 17.11% to $19.9 million in 2022, then increased by 18.64% to $23.6 million in 2023, then rose by 14.01% to $26.9 million in 2024, then rose by 15.30% to $30.1 million in 2025.
  • Its last three reported values are $30.1 million in Q3 2025, $28.5 million for Q2 2025, and $27.9 million during Q1 2025.